| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 80.11B | 82.59B | 79.62B | 79.23B | 66.09B | 62.39B |
| Gross Profit | 23.20B | 23.34B | 18.37B | 12.01B | 7.04B | 15.18B |
| EBITDA | 16.81B | 17.60B | 13.53B | 7.41B | -2.62B | 9.81B |
| Net Income | 10.33B | 10.85B | 7.89B | 3.66B | -4.72B | 4.98B |
Balance Sheet | ||||||
| Total Assets | 77.19B | 82.39B | 79.14B | 70.48B | 63.64B | 65.63B |
| Cash, Cash Equivalents and Short-Term Investments | 7.31B | 14.17B | 16.35B | 11.88B | 7.38B | 11.37B |
| Total Debt | 4.90B | 5.08B | 6.00B | 7.22B | 7.69B | 2.11B |
| Total Liabilities | 18.02B | 22.67B | 25.98B | 24.33B | 21.22B | 17.59B |
| Stockholders Equity | 59.14B | 59.68B | 53.11B | 46.09B | 42.35B | 47.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.20B | 7.54B | 5.08B | -8.48B | 4.74B |
| Operating Cash Flow | 0.00 | 8.18B | 12.09B | 6.88B | -5.10B | 7.89B |
| Investing Cash Flow | 0.00 | -5.60B | -4.56B | -1.63B | -3.36B | -3.11B |
| Financing Cash Flow | 0.00 | -4.76B | -3.06B | -756.00M | 4.47B | -1.37B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥49.27B | 7.14 | ― | 6.31% | -8.44% | 9.50% | |
71 Outperform | ¥71.44B | 8.43 | ― | 5.15% | -9.28% | -7.18% | |
70 Outperform | ¥104.34B | 10.61 | ― | 3.70% | -3.06% | 1.15% | |
64 Neutral | ¥33.51B | -185.54 | ― | 5.02% | -13.64% | -45.74% | |
64 Neutral | ¥52.37B | 7.67 | ― | 6.27% | -7.45% | -9.12% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥74.23B | 53.99 | ― | 1.24% | -12.05% | -97.36% |